Updates
** Shares of medical products maker Baxter International BAX.N fall 15.3% to $18.98, its lowest in over two decades
** Co trims its forecasts for adjusted annual profit and revenue growth
** Now expects annual adjusted profit between $2.35 and $2.40 per share; analysts expect a profit of $2.44 per share, as per LSEG-compiled data
** Co reports Q3 revenue of $2.84 billion, vs est of $2.88 billion
** Co posts adjusted quarterly profit of 69 cents per share, surpassing estimates of 60 cents
** Co lowers its annual sales growth forecast to a range of 4% to 5%
** "We remain concerned about multiple quarters of weaker topline delivery," Citi analysts said
** Including session's move, BAX stock was down ~35% YTD
(Reporting by Sahil Pandey and Padmanabhan Ananthan)
((Sahil.Pandey@thomsonreuters.com))